InMed Pharmaceuticals Inc (INM)
NASDAQ
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -90.293 | -46.82 | -55.4 | -79.882 | -116.049 | -164.828 | -59.106 | -59.208 |
Return on Equity (%) | -99.978 | -48.565 | -58.455 | -92.612 | -153.961 | -226.071 | -75.094 | -72.092 |
Return on Invested Capital (%) | -99.978 | -48.548 | -59.778 | -93.601 | -145.324 | -163.791 | -78.827 | -74.862 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -1707.989 | -191.852 | -166.79 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -1707.989 | -192.166 | -166.942 |
Book Value Per Share | 0.052 | 0.151 | 0.099 | 0.917 | 0.784 | 10.707 | 3.048 | 0.832 |
Earnings Per Share | -0.035 | -0.05 | -0.077 | -1.712 | -1.267 | -28.571 | -2.388 | -0.861 |
Cash Per Share | 0.053 | 0.141 | 0.075 | 1.112 | 0.915 | 9.488 | 2.678 | 0.737 |
Working Capital Per Share | 0.052 | 0.151 | 0.099 | 0.888 | 0.765 | 9.644 | 2.804 | 0.753 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.836 | 0.422 | 0.123 |
EBIT Per Share | -0.035 | -0.05 | -0.077 | -1.712 | -1.267 | -28.571 | -2.384 | -0.86 |
EBITDA Per Share | -0.035 | -0.05 | -0.077 | -1.712 | -1.267 | -28.571 | -2.384 | -0.86 |
Free Cash Flow Per Share | -0.036 | -0.05 | -0.077 | -1.725 | -1.282 | -28.797 | -2.401 | -0.884 |
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 127,65M | 170,85M | 172,28M | 5,22M | 8,05M | 651k | 3,33M | 8,92M |
Fin d'année 30 Juin 2024 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 1,59M | 3,33M | 3,33M | 3,33M | 5,67M | 6,35M | 8,92M | 667k |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | -281.264 | N/A | N/A | N/A | -132.648 |
Net Profit Margin (%) | N/A | N/A | N/A | -281.264 | N/A | N/A | N/A | -132.648 |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,72M |
Ratio cours/bénéfice | -0,35 |
Ratio prix/ventes | 0,59 |
Ratio prix/liquidités | 0,41 |
Ratio prix/valeur comptable | 0,3 |
Rendement de dividende | - |
Actions en circulation | 667,67k |
Volume moyen (1 semaine) | 46,17k |
Volume moyen (1 mois) | 26,95k |
Variation sur 52 semaines | -46,32% |
Plus haut sur 52 semaines | 15,576 |
Plus bas sur 52 semaines | 2,414 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales